SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-161649
Filing Date
2023-06-06
Accepted
2023-06-06 16:26:53
Documents
12
Period of Report
2023-05-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d418639d8k.htm   iXBRL 8-K 26470
  Complete submission text file 0001193125-23-161649.txt   152423

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20230531.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20230531_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20230531_pre.xml EX-101.PRE 11701
6 EXTRACTED XBRL INSTANCE DOCUMENT d418639d8k_htm.xml XML 3511
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 23996429
SIC: 8071 Services-Medical Laboratories